Peptide Research Information

Mechanism of action, research history, notable studies, and common research protocols for each peptide. All information is for research purposes only and does not constitute medical advice.

Research purposes only. This information does not constitute medical advice. Always consult a qualified healthcare professional before considering any substance for personal use.

BPC-157

Body Protection Compound 157, Pentadecapeptide BPC 157

A stable 15-amino acid gastric peptide studied for tissue repair and cytoprotection.

Pentadecapeptide / Gastroprotective peptide

1419.56 Da

4 studies2 protocols

TB-500

Thymosin Beta-4, Tβ4

A synthetic form of Thymosin Beta-4, a ubiquitous actin-sequestering protein studied for wound healing and tissue regeneration.

Beta-thymosin / Actin-sequestering peptide

~4,963 Da (44-residue form)

4 studies2 protocols

Semaglutide

Ozempic, Wegovy

A long-acting GLP-1 receptor agonist with established efficacy in type 2 diabetes and obesity clinical trials.

GLP-1 receptor agonist / Incretin mimetic

4,113.58 Da

4 studies2 protocols

Tirzepatide

Mounjaro, Zepbound

The first dual GIP and GLP-1 receptor agonist, demonstrating superior weight loss and glycemic control in large clinical trials.

Dual GIP/GLP-1 receptor agonist / Dual incretin mimetic

4,813.48 Da

4 studies2 protocols

CJC-1295

Modified GRF 1-29, Mod GRF 1-29

A GHRH analog engineered for extended half-life, studied for its ability to stimulate sustained pulsatile growth hormone release.

GHRH analog / Growth hormone secretagogue

~3,367 Da (without DAC) / ~3,647 Da (with DAC)

3 studies2 protocols

This information is for research purposes only and does not constitute medical advice. Peptides listed here may not be approved for human use in your jurisdiction.